Device Spine

Sternalock

Payments companies reported to CMS as associated with Sternalock. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$228Kassociated payments (2023-2025)
239clinicians with associated payments
1company reporting

By year

2023 $3,413
2024 $166K
2025 $58K

Payments reported as associated with Sternalock, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $198K
Surgical $14K
Physician Assistant $11K
Surgery $1,247
Vascular Surgery $407
Anesthesiology $328

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Sternalock

These are the largest totals companies reported as associated with Sternalock. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mark Bonnell Chattanooga, TN Thoracic Surgery (Cardiothoracic Vascular Surgery) $43,380.10
John Grehan Sioux Falls, SD Thoracic Surgery (Cardiothoracic Vascular Surgery) $43,139.76
Darien Bradford Burleson, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $43,056.69
J Morales Corpus Christi, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $21,508.24
Keith Allen Kansas City, KS Thoracic Surgery (Cardiothoracic Vascular Surgery) $13,457.03
Matthew Petrides Neptune, NJ Surgical $12,740.15
Nishant Patel Palm Beach Gardens, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $8,500.00
Daniel Dibardino Toledo, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $6,628.56
Pablo Ruda Vega Cleveland, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,346.57
Robert Dubose Portland, OR Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,178.32

Prescribed Sternalock?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.